tirzepatide surmount-1 weight loss percent nejm 2022 Tirzepatide: In the trial, reduction percentages were dose-dependent: 5 mg: ~15.0% weight reduction. 10 mg: ~19.5% weight reduction. 15 mg: ~20.9% weight reduction (Jastreboff et al., 2022). https://www.nejm.org/doi/10.1056 Tirzepatide versus Semaglutide Once Weekly

Among the subset of individuals who did not use insulin at baseline, approximately 2.0% and 4.1% of semaglutide and DPP4i users, respectively, initiated insulin during follow-up (Fig

If progress stalls for one to two weeks but you are maintaining healthy habits, trust the process before requesting a dose increase

Wegovy May Provide a Holistic Approach to Treating Liver Disease This new evidence suggests that Wegovy could be an important treatment option in the future for MASH, though it is not yet FDA-approved for this use

Although GLP-1 drug manufacturers agreed to a $245 net price, a substantial discount off prevailing list prices, savings to plans from a lower price may have been insufficient to offset higher costs associated with an uptake in GLP-1 use for obesity treatment

It works by inhibiting melanin production: Glutathione interferes with the enzyme tyrosinase, which handles melanin synthesis, the pigment that gives skin its color